Latest Scheme Of Arrangement News

Page 12 of 50
Lynch Group Holdings Limited is moving closer to a $269 million acquisition by Hasfarm Bidco, with a shareholder meeting scheduled for 21 November 2025 to vote on the proposed scheme of arrangement. The transaction offers Lynch shareholders a 23% premium and is backed by an independent expert report and unanimous board recommendation.
Victor Sage
Victor Sage
21 Oct 2025
Duxton Farms has secured Federal Court approval to merge four private agricultural companies, setting the stage for a significant expansion in walnuts, dried fruits, orchards, and bees. The merger is expected to complete by the end of October, accompanied by new financing arrangements.
Ada Torres
Ada Torres
21 Oct 2025
Mayne Pharma has announced the rescheduling of its Supreme Court hearing to November 3, 2025, to approve the acquisition scheme by Cosette Australia BidCo, pending Foreign Investment Review Board approval.
Ada Torres
Ada Torres
21 Oct 2025
Vonex Limited has finalized its Scheme of Arrangement, transferring all shares to Maxo Telecommunications and initiating a board overhaul ahead of its imminent ASX delisting.
Sophie Babbage
Sophie Babbage
20 Oct 2025
United States Antimony Corporation has proposed acquiring Larvotto Resources in a deal that could create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium.
Maxwell Dee
Maxwell Dee
20 Oct 2025
United States Antimony Corporation has made a non-binding indicative offer to acquire Larvotto Resources at a significant premium, proposing a strategic merger focused on antimony supply chain security and growth.
Maxwell Dee
Maxwell Dee
20 Oct 2025
The ASX has granted key waivers allowing Southern Cross Media to proceed with its acquisition of Seven West Media without shareholder approval, smoothing the way for a major media consolidation.
Elise Vega
Elise Vega
17 Oct 2025
Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.
Victor Sage
Victor Sage
16 Oct 2025
Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.
Victor Sage
Victor Sage
16 Oct 2025
NSX Limited’s shares have been suspended from trading following Federal Court approval of its acquisition by an Ontario-based entity linked to CNSX Markets Inc. This marks a significant shift in ownership for the Australian stock exchange operator.
Claire Turing
Claire Turing
15 Oct 2025
Aurumin Limited has sent out its Scheme Booklet detailing the proposed acquisition by Brightstar Resources, setting the stage for shareholder meetings in November. Securityholders are urged to review the materials carefully before voting.
Maxwell Dee
Maxwell Dee
15 Oct 2025
NSX Limited confirms the legal effectiveness of its acquisition by a Canadian entity, with trading suspended and shareholder payments scheduled.
Claire Turing
Claire Turing
15 Oct 2025